Close Menu

UMass

A Massachusetts District Court this week denied motions to dismiss an intellectual property-ownership lawsuit filed by the University of Utah against Alnylam Pharmaceuticals and several University of Massachusetts officials, among others, telling the defendants that they have not

The University of Utah last week fired back at a bid by University of Massachusetts officials to have an RNAi technology intellectual property lawsuit dismissed, arguing that the court hearing the case — and not the US Supreme Court, as the officials contend — is the appropriate

Silence Therapeutics has scored a victory in its efforts to defend its intellectual property estate, announcing this week that the US Patent and Trademark Office has upheld the validity of four patents related to the design of RNAi molecules.

Pages

The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.

The Japan News writes that Japan needs to seize the opportunity to ensure that a wide number of people benefit from personalized cancer treatments.

There's increasing genetic evidence that a number of ancient hominins may have contributed to the human gene pool, according to Discover's The Crux blog.

In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.